SNY vs TEVA

Sanofi against Teva Pharmaceutical Industries Limited — live side-by-side technical comparison.

Prices as of 2026-09-23T20:00:01+00:00 UTC · updates daily

Who leads right now

TEVA leads 5 of the 5 windows we measure — over 1 month SNY is -8.8% and TEVA +5.6%; over year to date SNY is -14.0% and TEVA +25.0%. The SNY/TEVA price ratio stands at 1.0679, below its 50-day average of 1.2316, and below the 200-day average of 1.3704. A ratio above its own average means SNY is gaining on TEVA; on this reading the recent edge belongs to TEVA.

Performance side by side

SNYTEVA
Price$41.66 $39.01
1 day -2.0% -1.3%lead
5 days -2.2% +1.2%lead
1 month -8.8% +5.6%lead
6 months -7.0% +35.6%lead
Year to date -14.0% +25.0%lead
52-week position 7% of range 92% of range
52-week range $40.89–$52.68 $18.21–$40.79
vs 50-day average below $43.82 above $35.79
vs 200-day average below $45.32 above $33.32
RSI (14) 25 59
Next earnings 2026-10-302026-11-03

Where each one stands

SNY — Sanofi

SNY trades at $41.66, below its 50-day average of $43.82, and below the 200-day at $45.32. It sits at 7% of its 52-week range ($40.89–$52.68); 14-day RSI is 25, in oversold territory; an average session moves it about 1.7%. For levels, the first level overhead is $42.31 (1.6% away) and the first support below is $41.33 (0.8% down). On the checklist the page runs for every asset, 0 of 6 checks read bullish — the lean is bearish.

TEVA — Teva Pharmaceutical Industries Limited

TEVA trades at $39.01, above its 50-day average of $35.79, and above the 200-day at $33.32. It sits at 92% of its 52-week range ($18.21–$40.79); 14-day RSI is 59, in neutral territory; an average session moves it about 3.3%. For levels, the first level overhead is $40.00 (2.5% away) and the first support below is $35.79 (8.2% down). On the checklist the page runs for every asset, 6 of 6 checks read bullish — the lean is bullish.

Which one moves harder

TEVA is the more volatile of the two — an average session moves it 3.3% against 1.7% for SNY, so an identical position size carries roughly 1.9× the daily risk.

What would change the picture

The comparison turns on those levels: SNY clearing $42.31 or losing $41.33; TEVA clearing $40.00 or losing $35.79. Until one of them gives way, the relative reading above stands.

Questions people ask about SNY vs TEVA

Which is performing better right now, SNY or TEVA?
Over the past month SNY is -8.8% and TEVA is +5.6%, so TEVA is ahead on that window. Year to date the figures are -14.0% for SNY and +25.0% for TEVA.
Is SNY or TEVA more volatile?
TEVA is the more volatile of the two — an average session moves it 3.3% against 1.7% for SNY, so an identical position size carries roughly 1.9× the daily risk.
What are the key levels for SNY and TEVA?
SNY: resistance $42.31, support $41.33; TEVA: resistance $40.00, support $35.79. Levels come from recent swing zones and round numbers, recomputed daily.
When do SNY and TEVA report next?
SNY: 2026-10-30. TEVA: 2026-11-03. Earnings reset both the trend and the levels above, so a comparison made today is only good until the next report.
What does the SNY/TEVA ratio mean?
It is simply SNY's price divided by TEVA's — 1.0679 today. When the ratio rises, SNY is outperforming; when it falls, TEVA is. Comparing it to its own 50- and 200-day averages shows whether the current leadership is new or long-standing.

Full technical reads

SNY →
Sanofi
Full technical read: trend, levels, chart, news
TEVA →
Teva Pharmaceutical Industries Limited
Full technical read: trend, levels, chart, news

Related comparisons

ABBV vs LLYLLY vs UNHDHR vs LLYLLY vs SNYEL.PA vs LLYLLY vs MRNABAYN.DE vs LLYABBV vs UNH